DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20202456

Anti-epileptic drugs adherence of epilepsy patients in Indonesia

Arthur H. P. Mawuntu, Herlyani Khosama, Corry N. Mahama, Sekplin A. S. Sekeon, Karema Winifred

Abstract


Background: Adherence to medication is an important component of successful epilepsy treatment. However, the disease’s long-term treatment makes it difficult to achieve good adherence. This study aimed to assess the adherence level of anti-epileptic drugs (AEDs) among adult epilepsy patients in Indonesia and its associated factors.

Methods: We reviewed the medical records of epilepsy patients in a tertiary public hospital between September 2018 and August 2019. Subjects were patients who were electro-clinically diagnosed with any type of epilepsy, have been taken at least one AED for at least three months, have a record of Morisky medication adherence scale 8 items (MMAS-8) score, and aged 20 years old and above. The level of adherence was measured by the MMAS-8 Indonesian version.

Results: We found 97 eligible subjects and the majority were males (56.7%), unemployed (69.1%), and aged ≥30 years old (55.7%). Most subjects (41.2%) showed a high adherence level. The remaining 30.9% and 27.8% had a moderate and low adherence level respectively.

Conclusions: This study reveals that high AEDs adherence is associated with being male, younger than 30 years of age, received monotherapy instead of polytherapy, and no memory impairment. A further investigation related to the reason why these factors play roles in the Indonesian setting is important to design appropriate strategies to improve AEDs adherence of epilepsy patients.

 


Keywords


Epilepsy, Anti-epileptic drug adherence, MMAS-8, Indonesia

Full Text:

PDF

References


Neligan A, Sander J. The incidence and prevalence of epilepsy. In: Rugg-Gunn FJ, Stapley HB, eds. Epilepsy 2017 From Bench to Bedside: A Practical Guide to Epilepsy. 16th ed. Oxford: ILAE (British Chapter); 2017: 3-10.

Zachry WM, Doan QD, Smith BJ, Clewell JD, Griffith JM. Direct medical costs for patients seeking emergency care for losses of epilepsy control in a U.S. managed care setting. Epilepsy Behav. 2009;16(2):268-73.

Faught E. Adherence to anti-epilepsy drug therapy. Epilepsy Behav. 2012;25:297-302.

Sabate E. Defining adherence. In: Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO; 2003: 3-6.

Buck D, Jacoby A, Baker GA, Chadwick DW. Factors influencing compliance with antiepileptic drug regimes. Seizure. 1997;6(2):87-93.

Malek N, Heath CA, Greene J. A review of medication adherence in people with epilepsy. Acta Neurol Scand. 2016;10:1-9.

Paschal AM, Rush SE, Sadler T. Factors associated with medication adherence in patients with epilepsy and recommendations for improvement. Epilepsy Behav. 2014;31:346-50.

Piper K, Richman J, Faught E. Adherence to antiepileptic drugs among diverse older Americans on Part D Medicare. Epilepsy Behav. 2017;66:68-73.

Sutula TP, Hagen J, Pitkanen A. Do epileptic seizures damage the brain. Curr Opin Neurol. 2003;16:189-95.

Faught RE, Weiner JR, Guerin A, Cunnington MC, Duh MS. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: Findings from the RANSOM study. Epilepsia. 2009;50(3):501-9.

Voils CI, Hoyle RH, Thorpe CT, MacIejewski ML, Yancy WS. Improving the measurement of self-reported medication nonadherence. J Clin Epidemiol. 2011;64:250-4.

Choo PW, Rand CS, Inui TS. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37(9):846-57.

Vik SA, Maxwell CJ, Hogan DB, Patten SB, Johnson JA, Slack RL. Assessing medication adherence among older persons in community settings. Can J Clin Pharmacol. 2005;12(1):152-64.

Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;355(5):487-97.

Morisky DE, Ang A, Wood KM, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348-54.

Gupta S, Goren A. Application of Item Response Theory in Validating the Morisky Medication Adherence Scale in Patients with Hypertension. Value Heal. 2013;16:4.

Qazaz AHK, Hassali MA, Shafie AA, Sulaiman SA, Sundram S, Morisky DE. The eight items Morisky Medication Adherence Scale MMAS: Translation and validation of the Malaysian version. Diabetes Res Clin Pract. 2010;90:216-21.

Savoldelli KV, Gillaizeau F, Pouchot J. Validation of a French Version of the 8 items Morisky Medication Adherence Scale in Hypertensive Adults. J Clin Hypertens. 2012;14(7):429-34.

Vika, Siagian M, Wangge G. Validity and reliability of Morisky Medication Adherence Scale 8 Bahasa version to measure statin adherence among military pilots. Heal Sci J Indones. 2016;7(2):129-33.

Moharamzad Y, Saadat H, Shahraki NB. Validation of the Persian Version of the 8 items Morisky Medication Adherence Scale (MMAS-8) in Iranian Hypertensive Patients. Glob J Health Sci. 2015;7(4):173-83.

Gast A, Mathes T. Medication adherence influencing factors - An (updated) overview of systematic reviews. Syst Rev. 2019;8(1):1-17.

Modi AC, Morita DA, Glauser TA. One-month adherence in children with new-onset epilepsy: White-coat compliance does not occur. Pediatrics. 2008;121(4):961-6.

Shetty J, Greene SA, Naranjo MO, Kirkpatrick M. Adherence to antiepileptic drugs in children with epilepsy in a Scottish population cohort. Dev Med Child Neurol. 2016;58:469-74.

Chinnaiyan S, Narayana S, Nanjappa VP. Adherence to Antiepileptic Therapy in Adults. J Neurosci Rural Pract. 2017;8:417-20.

Ferrari CMM, Sousa RMC, Castro LHM. Factors associated with treatment non-adherence in patients with epilepsy in Brazil. Seizure. 2013;22:384-9.

Elsayed MA, Sayed ENM, Badi S, Ahmed MH. Factors affecting adherence to antiepileptic medications among Sudanese individuals with epilepsy: A cross‑sectional survey. J Fam Med Prim Care. 2019;8:2312-7.

Ettinger AB, Manjunath R, Candrilli SD, Davis KL. Prevalence and cost of nonadherence to antiepileptic drugs in elderly patients with epilepsy. Epilepsy Behav. 2009;14:324-9.

Guo Y, Ding XY, Lu RY. Depression and anxiety are associated with reduced antiepileptic drug adherence in Chinese patients. Epilepsy Behav. 2015;50:91-5.

Gurumurthy R, Chanda K, Sarma GRK. An evaluation of factors affecting adherence to antiepileptic drugs in patients with epilepsy: A cross-sectional study. Singapore Med J. 2017;58(2):98-102.

Niriayo YL, Mamo A, Gidey K, Demoz GT. Medication belief and adherence among patients with epilepsy. Behav Neurol. 2019;2019:1-7.

Auley MJW, Passen N, Prusa C, Dixon J, Hart CS, Shneker BF. An evaluation of the impact of memory and mood on antiepileptic drug adherence. Epilepsy Behav. 2015;43:61-5.

Das AM, Ramamoorthy L, Narayan SK, Wadwekar V. Barriers of Drug Adherence among Patients with Epilepsy: in Tertiary Care Hospital, South India. J Caring Sci. 2018;7(4):177-81.

Mawuntu AHP, Mahama CN, Sekeon SAS, Winifred K, Khosama H. Kepatuhan minum obat antiepilepsi pada pasien epilepsi di Manado, Indonesia. J Sinaps. 2019;2(3):19-24.

Harimanana A, Clavel S, Chivorakul P, Perez F, Preux PM, Barennes H. Associated factors with adherence to antiepileptic drug in the capital city of Lao PDR. Epilepsy Res. 2013;104:158-66.

Nicoletti A, Reggio A, Bartoloni A. Prevalence of epilepsy in rural Bolivia: a door-to-door survey. Neurology. 1999;53:2064-9.

Liu J, Liu Z, Ding H, Yang X. Adherence to treatment and influencing factors in a sample of Chinese epilepsy patients. Epileptic Disord. 2013;15(3):289-94.

Gollwitzer S, Kostev K, Hagge M, Lang J, Graf W, Hamer HM. Nonadherence to antiepileptic drugs in Germany. Neurology. 2016;87:1-7.

Tanoto E, Yulianne M, Khosama H, Mahama CN, Jehosua SY. Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile in Prof. RD Kandou Hospital Manado, Indonesia. In: 33-Rd International Epilepsy Congress. Bangkok: ILAE; 2019:508.

Sander J, Gunn RF. Overview of established antiepileptic drugs. In: Rugg-Gunn FJ, Stapley HB, eds. Epilepsy 2017 From Bench to Bedside: A Practical Guide to Epilepsy. 16th ed. Oxford: ILAE (British Chapter); 2017:319-36.

Carbone L, Zebrack B, Plegue M, Joshi S, Shellhaas R. Treatment adherence among adolescents with epilepsy. Epilepsy Behav. 2013;27(1):59-63.